2016
DOI: 10.1556/004.2016.015
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial susceptibility of Bacillus anthracis strains from Hungary

Abstract: The susceptibility of 29 Bacillus anthracis strains, collected in Hungary between 1933 and 2014, was tested to 10 antibiotics with commercially available minimum inhibitory concentration (MIC) test strips. All strains were susceptible to amoxicillin, ciprofloxacin, clindamycin, doxycycline, gentamicin, penicillin, rifampicin, and vancomycin. Intermediate susceptibility to erythromycin and cefotaxime was detected in 17.2% (5/29) and 58.6% (17/29) of the strains, respectively. Correlations were not observed betw… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…However, no such effects were observed in our experiments. During our literature search, three other antibiotics, rifampicin, daptomycin and linezolid, were also identified as potentially interesting substances (Table 2) which, apparently, can be tolerated by B. anthracis in higher concentrations than its related species (Dabbs et al 1995;Bryskier 2002;Cavallo et al 2002;Mohammed et al 2002;Citron and Appleman 2006;Luna et al 2007;Horii et al 2011;Ikeda et al 2015;Kreizinger et al 2016). During our experiments, these substances were not able to improve CEFOMA selectivity with the tested panel of non-target reference strains.…”
Section: Discussionmentioning
confidence: 88%
See 1 more Smart Citation
“…However, no such effects were observed in our experiments. During our literature search, three other antibiotics, rifampicin, daptomycin and linezolid, were also identified as potentially interesting substances (Table 2) which, apparently, can be tolerated by B. anthracis in higher concentrations than its related species (Dabbs et al 1995;Bryskier 2002;Cavallo et al 2002;Mohammed et al 2002;Citron and Appleman 2006;Luna et al 2007;Horii et al 2011;Ikeda et al 2015;Kreizinger et al 2016). During our experiments, these substances were not able to improve CEFOMA selectivity with the tested panel of non-target reference strains.…”
Section: Discussionmentioning
confidence: 88%
“…Not surprisingly, the susceptibility to most antibiotics among the B. cereus sensu lato group was, in general, rather similar. However, in case of the two macrolide antibiotics erythromycin and azithromycin, it was noted that strains of B. anthracis exhibited higher tolerance towards these substances than many other strains of the B. cereus sensu lato group (Yamamoto et al 2001;Bryskier 2002;Cavallo et al 2002;Mohammed et al 2002;Frean et al 2003;Jones et al 2003;Schlegelova et al 2003;Turnbull et al 2004;Citron and Appleman 2006;Luna et al 2007;Ikeda et al 2015;Kreizinger et al 2016). It is important to note that many strains of B. anthracis are defined as being sensitive to erythromycin and azithromycin (Turnbull 2008).…”
Section: Agar Development and Specificity Testingmentioning
confidence: 99%
“…In order to validate clade-specific SNPs identified by whole genome SNP-discovery, and to determine the distribution of these SNPs in additional B. anthracis DNAs, novel PCR assays were designed and tested. The new assay method is a probe-less real-time qPCR hybrid based on the Melt-MAMA test [20], previously used by us [4,13] or others [21], and an older melt-independent approach employing two separate PCR-reactions to interrogate for alternate allele states, ARMS (Amplification Refractory Mutation System) [22]. Our hybrid method makes use of mismatch (forward) primers featuring an additional mismatch to both alleles at the antepenultimate (-3) position [20] and the allele-specific match/mismatch at the 3'-position like in melt-MAMA and ARMS.…”
Section: Interrogation Of Snps Via Pcr By Relative Ct-value Analysis mentioning
confidence: 99%